Biotech Values

[mcbio]

That’s certainly not my view with respect to ENTA. Today’s Sovaldi pricing info for EU countries (#msg-96800767) makes me pretty sure that the pricing assumptions in my ENTA valuation model are still too low even though I recently raised them (#msg-94993406).

With no more skin in the HCV game, while skeptical, I'm pulling for you ENTA longs to bank a lot of further upside from what you have already experienced.

p.s. I realize that you can't buy ENTA because the market cap is too high :- )

Correct. ; )